The Aesthetics Group of OrthoNeturogena, a division of Ortho-McNeil-Janssen Pharmaceuticals and part of the Johnson & Johnson family of companies, announced FDA approval of a new collagen-based dermal filler.

Announcement:  Aesthetics Group of OrthoNeutrogena Press Release

Posted: January 21st, 2009 by Menopause Alliance

You can leave a response, or trackback from your own site.

Leave a Reply

Name (required) Email (not published) (required) Website (optional)